These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10499670)

  • 21. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    US Public Health Service, Infectious Diseases Society of America, Prevention of Opportunistic Infections Working Group
    Infect Dis Obstet Gynecol; 2002; 10(1):3-64. PubMed ID: 12090361
    [No Abstract]   [Full Text] [Related]  

  • 22. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.
    MMWR Recomm Rep; 1995 Jul; 44(RR-8):1-34. PubMed ID: 7565547
    [No Abstract]   [Full Text] [Related]  

  • 23. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.
    Ann Intern Med; 1996 Feb; 124(3):349-68. PubMed ID: 8554235
    [No Abstract]   [Full Text] [Related]  

  • 24. USPHS and IDSA collaborate on guidelines to prevent opportunistic infections in HIV-infected persons.
    Kaplan JE; Holmes KK
    Emerg Infect Dis; 1995; 1(3):102-3. PubMed ID: 8903176
    [No Abstract]   [Full Text] [Related]  

  • 25. [Guidelines for the prevention of opportunistic infections in persons with HIV or AIDS in Latin America and the Caribbean. USPHS/IDSA].
    Bol Oficina Sanit Panam; 1996 Nov; 121(5):377-415. PubMed ID: 9011171
    [No Abstract]   [Full Text] [Related]  

  • 26. 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV: Part I. Prevention of Exposure.
    Am Fam Physician; 2000 Jan; 61(1):163-74. PubMed ID: 10643957
    [No Abstract]   [Full Text] [Related]  

  • 27. An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons.
    Kaplan JE; Masur H; Holmes KK; Freedberg KA; Holtgrave D; Piscitelli SC; Van Dyke R; Watts H
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S15-28. PubMed ID: 10770912
    [No Abstract]   [Full Text] [Related]  

  • 28. Preaching what we practice: new guidelines for OI prophylaxis.
    Feinberg J
    AIDS Clin Care; 1999 Nov; 11(11):87-9, 94. PubMed ID: 11366709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latest opportunistic infection prevention guidelines.
    D'Amico R
    Posit Aware; 1998; 9(1):43-4. PubMed ID: 11365000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1997 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV: Part II. Prevention of first episode of disease.
    Am Fam Physician; 1997 Sep; 56(4):1131-46. PubMed ID: 9310065
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines issued for prevention of opportunistic infections in persons with HIV.U.S. Public Health Service and Infectious Disease Society of America.
    Am Fam Physician; 1995 Nov; 52(6):1922, 1924-7. PubMed ID: 7484696
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of opportunistic infections in HIV infected patients. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America].
    Bornkessel B
    Med Monatsschr Pharm; 1996 Jul; 19(7):206-14. PubMed ID: 8766923
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylaxis against opportunistic infections in persons infected with human immunodeficiency virus.
    Martin JE; Besch CL; ;
    Am J Med Sci; 2004 Jul; 328(1):64-9. PubMed ID: 15254443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus.
    Gross PA; Asch S; Kitahata MM; Freedberg KA; Barr D; Melnick DA; Bozzette SA
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S85-93. PubMed ID: 10770917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of opportunistic infections in the era of improved antiretroviral therapy.
    Chaisson RE; Moore RD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S14-22. PubMed ID: 9389311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update: prophylaxis for HIV opportunistic infections.
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(1):5-6. PubMed ID: 11365025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuation of prophylaxis in HAART-responders.
    Maenza J
    Hopkins HIV Rep; 1999 Jul; 11(4):2-3. PubMed ID: 11366923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunistic infections update.
    Proj Inf Perspect; 1999 Sep; (28):11-3. PubMed ID: 11367355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
    Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
    Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.